Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in Aberrant Crypt Foci of the Colon
NCT00754494Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2008
- Primary completion
- Oct 2012
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in colorectal cancer (CRC), adenomatous polyp, sponsored by National Cancer Institute. Started Jul 2008; status: completed.
02
Drugs
erlotinib
03
Conditions
colorectal cancer (CRC)adenomatous polyp
Beyond the preview
Go deeper on NCT00754494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754494.